Analytic Validation of the Enzyme Multiplied Immunoassay Technique for the Determination of Mycophenolic Acid in Plasma From Renal Transplant Recipients Compared With a High-Performance Liquid Chromatographic Assay
Authors:
- Shiro TakaharaSTShiro Takahara
- Ryoichi ImamuraRIRyoichi Imamura
- Miyaji KyakunoMKMiyaji Kyakuno
- Toshiyuki TanakaTTToshiyuki Tanaka
- Koji YazawaKYKoji Yazawa
- Toru HanafusaTHToru Hanafusa
- Kiyami MatsumiyaKMKiyami Matsumiya
- Norio NonomuraNNNorio Nonomura
- Akihiko OkuyamaAOAkihiko Okuyama
- Hisashi SugimotoHSHisashi Sugimoto
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 23 (6) , 669-674
Abstract
The analysis of mycophenolic acid (MPA) has proved a valuable adjunct to the clinical care of organ transplant recipients. The analytic validation of the enzyme multiplied immunoassay technique (EMIT) for the determination of MPA in plasma is described. The EMIT MPA standard curve was 0 to 15.0 μg/mL, and curve storage was maintained for 4 weeks. The MPA EMIT assay proved reliable and reproducible, as shown by the intra-assay and interassay coefficients of variation (1.58–3.68% and 1.23–7.57%, respectively). Excellent linear correlation (r = 0.999) was observed for dilution linearity. The sensitivity of the assay was 0.01 μg/mL. Recoveries of 99.4% to 104.2% were obtained by spiking aliquots of three controls of known MPA concentrations with MPA. No interference was observed for endogenous substances and coadministered immunosuppressant drugs, and no cross-reactivity from the major metabolite MPA glucuronide was found. The high-performance liquid chromatography (HPLC) assay used protein precipitation and C18 ion-pair chromatography with ultraviolet detection at 304 nm. Plasma concentrations of MPA were measured using EMIT and HPLC. A linear relationship was observed between EMIT and HPLC (EMIT = 1.091 × HPLC - 0.089;r 2 = 0.990, n = 129). These results indicate that EMIT is a simple, rapid, and sensitive assay method for the measurement of MPA in plasma.Keywords
This publication has 12 references indexed in Scilit:
- Rapid and simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by ion-pair reversed-phase high-performance liquid chromatography using isocratic elutionJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Evaluation of an Immunoassay (EMIT) for Mycophenolic Acid in Plasma From Renal Transplant Recipients Compared With a High-Performance Liquid Chromatography AssayTherapeutic Drug Monitoring, 1998
- Therapeutic Drug Monitoring of Mycophenolic Acid: Comparison of HPLC and Immunoassay Reveals New MPA MetabolitesTransplantation Proceedings, 1998
- TACROLIMUS AND MMF IN CARDIAC TRANSPLANTATION: IMPORTANCE OF MYCOPHENOLIC ACID DRUG MONITORINGTransplantation, 1998
- Simple method for the quantitation of mycophenolic acid in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by a single-run ion-paring methodJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991
- MYCOPHENOLIC ACID AN ANTIBIOTIC FROM PENICILLIUM BREVICOMPACTUM DIERCKXThe Lancet, 1946